搜索筛选:
搜索耗时2.8691秒,为你在为你在102,285,761篇论文里面共找到 48 篇相符的论文内容
类      型:
[期刊论文] 作者:DOU Ke-fei,XU Bo,YANG Yue-jin,, 来源:中华医学杂志(英文版) 年份:2004
Background Drug-eluting stents (DES) have revolutionized the field of interventional cardiology by dramatically improving clinical and angiographic outcomes. Pa...
[期刊论文] 作者:XU Bo,DOU Ke-fei,YANG Yue-jin,, 来源:中华医学杂志(英文版) 年份:2004
Background Recent data have shown that sirolimus-eluting stents (SES) reduced not only the incidences of restenosis but also of target vessel revascularization...
[期刊论文] 作者:XU Bo,DOU Ke-fei,YANG Yue-jin,, 来源:中华医学杂志(英文版) 年份:2011
[期刊论文] 作者:DOU Ke-fei,XU Bo,YANG Yue-jin,, 来源:中华医学杂志(英文版) 年份:2008
Background Coronary artery disease (CAD) is generally considered as a disease of middle-aged men.It is widely accepted that the risk for CAD of premenopausal wo...
[期刊论文] 作者:DOU Ke-fei,XU Bo,YANG Yue-jin,, 来源:中华医学杂志(英文版) 年份:2009
[会议论文] 作者:DOU Ke-Fei,YANG Min-Fu,YANG Yue-jin, 来源:2008年中国介入心脏病学大会 年份:2008
[会议论文] 作者:DOU Ke-Fei,YANG Min-Fu,YANG Yue-jin, 来源:2008年中国介入心脏病学大会 年份:2008
[期刊论文] 作者:XU Bo,DOU Ke-fei,HAN Ya-ling,L, 来源:中华医学杂志(英文版) 年份:2004
Background Available drug-eluting stents (DES) have achieved great success in reducing restenosis rates. Recently,investigators have demonstrated that the durab...
[期刊论文] 作者:XU Bo,DOU Ke-fei,HAN Ya-ling,L, 来源:中华医学杂志(英文版) 年份:2011
Background Available drug-eluting stents (DES) have achieved great success in reducing restenosis rates. Recently,investigators have demonstrated that the durab...
[期刊论文] 作者:ZHANG Dong,XU Bo,DOU Ke-fei,YA, 来源:中华医学杂志(英文版) 年份:2013
[会议论文] 作者:DOU Ke-fei,XU Bo,YANG Yue-jin,GAO Run-lin, 来源:第11届中国介入心脏病学大会 年份:2013
[会议论文] 作者:DOU Ke-fei,XU Bo,YANG Yue-jin,GAO Run-lin, 来源:第11届中国介入心脏病学大会 年份:2013
Background This study sought to evaluate the safety and efficacy of the NOYA stent which is a Cobalt Chromium-based sirolimus-eluting stent (SES) with DL-Polylactide biodegradable polymer (Medfavour M...
[会议论文] 作者:YIN Dong,DOU Ke-fei,XU Bo,YANG Yue-jin,YOU Shi-jie, 来源:第11届中国介入心脏病学大会 年份:2013
[会议论文] 作者:YIN Dong,DOU Ke-fei,XU Bo,YANG Yue-jin,YOU Shi-jie, 来源:第11届中国介入心脏病学大会 年份:2013
[会议论文] 作者:YIN Dong,DOU Ke-fei,XU Bo,YANG Yue-jin,YOU Shi-jie, 来源:第11届中国介入心脏病学大会 年份:2013
[会议论文] 作者:YIN Dong,DOU Ke-fei,YANG Yue-jin,XU Bo,YOU Shi-jie, 来源:第11届中国介入心脏病学大会 年份:2013
[会议论文] 作者:YIN Dong,DOU Ke-fei,YANG Yue-jin,XU Bo,YOU Shi-jie, 来源:第11届中国介入心脏病学大会 年份:2013
Background There are few studies comparing long-term outcomes of percutaneous coronary intervention (PCI) with different drug-eluting stents for chronic total o...
[会议论文] 作者:YIN Dong,DOU Ke-fei,XU Bo,YANG Yue-jin,YOU Shi-jie, 来源:第11届中国介入心脏病学大会 年份:2013
Background Long-term outcomes of percutaneous coronary intervention (PCI) with sirolimus-eluting stents (SES)compared to paclitaxel-eluting-stents (PES) in unselected diabetics in routine practice is...
[会议论文] 作者:YIN Dong,DOU Ke-fei,XU Bo,YANG Yue-jin,YOU Shi-jie, 来源:第11届中国介入心脏病学大会 年份:2013
Background To compare the safety and efficacy at 24 months after successful implantation of FIREBIRDsirolimus-eluting stents and TAXUS paclitaxel-eluting stents in Chinese population Methods From Apri...
[会议论文] 作者:YIN Dong,DOU Ke-fei,XU Bo,YANG Yue-jin,YOU Shi-jie, 来源:第11届中国介入心脏病学大会 年份:2013
Background Recent data has shown that sirolimus-eluting stents (SES) reduced not only the incidences of restenosis but also of target vessel revascularization (TVR).CYPHER and FIREBIRD stents are both...
相关搜索: